Vision is More Than 20/20
Vision is More Than 20/20
Dr. Miki Lyn Zilnicki
AXIM MMP-9 Testing for Dry Eyes!
14 minutes Posted Jul 12, 2022 at 9:00 am.
0:00
14:30
Download MP3
Show notes

The doctors are joined by John Huemoeller, CEO of AXIM Biotechnologies, who is a biotech leader on a mission to innovate the eye care industry with a new one-of-a-kind test that helps to diagnose people with Dry Eye Disease. 

As we know, Dry Eye Disease has been very difficult to diagnose due to its symptoms and many causes, it is estimated to impact at least 6.8% of the U.S. population. AXIM’s new MMP-9 test, which is the first rapid quantitative tear test for Matrix metalloproteinase-9 (MMP-9), an inflammatory biomarker for Dry Eye Disease, is set to change the future of DED diagnostics.

Tune in to listen to learn about the new technology and find more information about it at AXIMEYE!